Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Depression × Breast × Clear all

Phase

Phase NA 57 Phase 3 6 Phase 2 6 Phase 2/3 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Head & Neck 1 CNS 1 Breast 1

Conditions

Breast Neoplasms 153 Triple Negative Breast Neoplasms 21 Lung Neoplasms 15 Pancreatic Neoplasms 10 Ovarian Neoplasms 10 Colonic Neoplasms 10 Prostatic Neoplasms 9 Melanoma 9 Sarcoma 8 Stomach Neoplasms 7 Neoplasms 6 Colorectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Urinary Bladder Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Head and Neck Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Intraductal, Noninfiltrating 5 Uterine Cervical Neoplasms 4 Glioblastoma 4 Breast Neoplasms, Male 4 Small Cell Lung Carcinoma 3 Liver Neoplasms 3 Endometrial Neoplasms 3 Brain Neoplasms 3 Rectal Neoplasms 2 Osteosarcoma 2 Kidney Neoplasms 2 Invasive Breast Cancer 2 Inflammatory Breast Neoplasms 2

Interventions

Typhoid-Paratyphoid Vaccines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02415387 2024-07-24

IMPACT

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed

172 enrolled 14 charts

Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡